Brian is a go-to first-chair trial lawyer who has tried over 30 cases to verdict before juries across the country, achieving numerous full defense verdicts on behalf of his many clients in some of the most challenging jurisdictions in the country.
In recognition of his success, Brian is nationally ranked by Chambers in “Products Liability and Mass Torts.” Chambers describes Brian as “a litigation genius” who “sees problems before they even happen” and is “instrumental in getting favorable results.” Brian is also identified by Legal 500 as a “Leading Partner” in “Toxic Torts,” as well as recommended for “Consumer Products,” “General Commercial Disputes,” “Antitrust Civil Litigation,” and “Sports.” In 2023, he was named “Trial Lawyer of the Year” and “Top Product Liability Litigator” by Benchmark Litigation and led the trial team that received Benchmark’s “National Impact Case Award” for the defense verdict secured in Clark v. Monsanto. Brian is also a Benchmark “Top 100 Trial Lawyer” and “Litigation Star” and a two-time National Law Journal “Winning Litigator” finalist.
Most recently, Brian co-led the trial team that secured judgment as a matter of law for the NFL and its 32 member teams in a class action lawsuit challenging the distribution of the Sunday Ticket subscription package and the NFL’s media agreements more generally. Brian handled examinations of several key witnesses, including the cross-examination of the plaintiffs’ primary expert, a sports economist, laying the groundwork for the post-trial Daubert ruling excluding the testimony as unreliable. Brian subsequently delivered oral argument at the hearing regarding the NFL’s post-trial motions, resulting in a complete victory for the NFL.
Brian serves as national trial counsel for several clients in multi-district litigations and other consolidated litigations around the country, including Monsanto in its Roundup litigation. In that litigation, he delivered the first full defense verdict for Monsanto in a Los Angeles Superior Court case involving a boy diagnosed with cancer at age five. Brian has also obtained complete defense verdicts on behalf of Bayer, Eli Lilly, and Pfizer in products liability bellwether trials, including the first state court jury verdict for Bayer in the Xarelto litigation.
Brian has also played a critical role in winning cases before trial, including delivering multiple Daubert and summary judgment victories in multidistrict litigation for clients, such as for Medtronic in hernia mesh litigation and for Bayer in its Roundup litigation. These results have paid dividends in related cases that relied on the same testimony.
Brian’s other notable representations include:
- Lead trial counsel defending Altria Group, Inc. in the first government entity bellwether trial in multidistrict litigation arising out of Altria’s minority investment in JUUL Labs, Inc. Just one day after resting its case following Brian’s cross-examinations of three key plaintiff experts, plaintiffs agreed to a global settlement with Altria that favorably resolved over 6,000 e-vapor cases in state and federal courts.
- Lead trial counsel for Medtronic Inc. defending against allegations of monopolizing the market for advanced bipolar devices in federal court brought by competitor Applied Medical, claiming over $1 billion in damages.
- Lead trial counsel for a major chemical manufacturer in the Aqueous Film-Forming Foams (AFFF) Products Liability Litigation in the District of South Carolina, considered the most significant PFAS litigation in the country.
Updated Sep 2025
